Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Reply to: Noxious cold stimulation: pro–con perspectives on the hypothermic effect on experimentally evoked cough

Imran Satia, Emma Iovoli, Kimberley Holt, Ashley A. Woodcock, John Belcher, Jaclyn A. Smith
European Respiratory Journal 2021 57: 2100245; DOI: 10.1183/13993003.00245-2021
Imran Satia
1Division of Infection, Immunity and Respiratory Medicine, and Manchester Academic Health Science Centre, University of Manchester, Manchester, UK
2Dept of Medicine, Division of Respirology, McMaster University, Hamilton, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Imran Satia
Emma Iovoli
1Division of Infection, Immunity and Respiratory Medicine, and Manchester Academic Health Science Centre, University of Manchester, Manchester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kimberley Holt
1Division of Infection, Immunity and Respiratory Medicine, and Manchester Academic Health Science Centre, University of Manchester, Manchester, UK
3Manchester University, NHS Foundation Trust, Manchester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashley A. Woodcock
1Division of Infection, Immunity and Respiratory Medicine, and Manchester Academic Health Science Centre, University of Manchester, Manchester, UK
3Manchester University, NHS Foundation Trust, Manchester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Belcher
3Manchester University, NHS Foundation Trust, Manchester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jaclyn A. Smith
1Division of Infection, Immunity and Respiratory Medicine, and Manchester Academic Health Science Centre, University of Manchester, Manchester, UK
3Manchester University, NHS Foundation Trust, Manchester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jaclyn A. Smith
  • For correspondence: jacky.smith@manchester.ac.uk
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Cold-induced pain inhibits cough responses to capsaicin, and this contrasts with the effect of whole-body exposure to cold environments in animal models, which heightens the cough responses to some inhaled irritants. https://bit.ly/2MiZdN2

Reply to S. Zhong and co-workers:

We thank S. Zhong and co-workers for their interest and thoughtful letter in response to our manuscript, “The effect of pain conditioning on experimentally evoked cough: evidence of impaired endogenous inhibitory control mechanisms in refractory chronic cough” [1]. In this study we demonstrated that a painful cold stimulus, applied to the hand, inhibited cough responses to capsaicin in humans, and that this phenomenon (known as conditioned pain modulation, CPM) was impaired in patients with refractory chronic cough. Interestingly, the recent study performed by Dong et al. [2] also investigated the effects of cold on the cough reflex. They found placing guinea pigs in a cold environment had the opposite effect, heightening cough responses to cinnamaldehyde in animals repeatedly exposed to citric acid; the citric acid exposure being an attempt to emulate the hyperexcitability of the cough reflex observed in patients with chronic cough.

There are fundamental differences between these studies that may account for the conflicting results. These include different species, cough challenge agents and the relevance of the citric acid exposure model to refractory chronic cough. However, in our opinion, the disparity in findings highlights that the reflex responses evoked by a localised painful cold stimulus, i.e. descending inhibitory controls, are quite distinct from those activated when the whole body or majority of the skin surface is exposed to cold air, which provokes systemic acute physiological responses to cold. Similar contrasting observations have been made in the context of chronic pain. For example, the cold pressor test used in our study is the most commonly used paradigm for demonstrating inhibition of pain through CPM and impaired pain inhibition is well-established in patients with chronic pain syndromes [3]. However, this conflicts with studies reporting the enhancement of pain on exposure to cold environments and observations that humans working in cold conditions are at greater risk of chronic pain [4, 5].

A study comparing five different methods for inducing CPM found the cold pressor test and ischaemic occlusion produce similar CPM effects, but the cold pressor test was the most effective at inducing pain, and the CPM effect was greater [6]. The cold pressor test also has better repeatability between visits compared with ischaemic occlusion [7]. For these reasons, we adopted the cold pressor test in our study, and we would not predict any difference in the outcomes if an alternative conditioning stimulus, such as ischaemic pressure, was used. However, the cold pressor test does require specialist equipment and, therefore, ischaemic occlusion is more easily applied in clinical as opposed to research settings.

The authors also expressed their concern about tachyphylaxis occurring in our study. Tachyphylaxis does occur in all capsaicin cough challenges and is most marked when high concentrations of capsaicin are inhaled, especially if then followed by a lower concentration [8]. The use of a single concentration (ED50) of capsaicin (inhaled four times) helps to avoid excessive tachyphylaxis when repeated measures of cough responses are required, as the overall exposure of subjects to capsaicin is much less than when doubling concentrations are used to measure a standard C5 (concentration evoking five coughs). Moreover, for a 90-s cold-water immersion it would be impossible to measure a C5 in such a short time frame. As can be seen from our no intervention data a small (but not statistically significant) reduction in the number of coughs was seen in our study due to tachyphylaxis, but as this effect is the same for all the experimental conditions, this not a confounding factor and does not influence the results.

Finally, S. Zhong and co-workers also commented that the “change of coughing during cold water immersion” was not provided. We only measured cough frequency at baseline in this study, to characterise the patients, but did not collect further data on the intervention days. This was because the interventions only lasted for 90 s and so it would have been impossible to see changes in cough frequency during such a short time-period and unlikely that such a brief intervention would change cough frequency over the remainder of the 24 h period.

The mechanisms underlying chronic cough remain poorly understood; however, using established experimental paradigms to explore processes thought to be important in chronic pain, may be a route to improving our knowledge.

Shareable PDF

Supplementary Material

This one-page PDF can be shared freely online.

Shareable PDF ERJ-00245-2021.Shareable

Footnotes

  • Author contributions: I. Satia and J.A. Smith wrote the first draft of the manuscript. All authors reviewed the final manuscript and approved for submission.

  • Conflict of Interest: I. Satia reports personal fees for educational talks for GPs from GSK and AstraZeneca, grants and personal fees from Merck Canada, grant from ERS Respire 3 Marie Curie Fellowship, grant from Dept of Medicine, McMaster University (E.J. Moran Campbell Early Career Award), outside the submitted work. E. Iovoli has nothing to disclose. K. Holt has nothing to disclose. A.A. Woodcock reports personal fees for lectures from GlaxoSmithKline, personal fees for lectures and consultancy from Novartis, personal fees for consultancy from Chiesi, other (chairman; cough drug in phase 1) from Axalbion, other (chairman; food allergy diagnostics) from Reacta Biotech, other (chairman; charity owned clinical trials unit) from Medicines Evaluation Unit, outside the submitted work; and has a patent cough monitor licensed to Vitalograph. J. Belcher has nothing to disclose. J.A. Smith reports grants and personal fees for advisory board work and consultancy from GlaxoSmithKline, NeRRe Pharmaceuticals, Menlo, Bayer, Boehringer Ingleheim, Axalbion, Afferent and Merck, personal fees for consultancy from Genentech, Neomed, Bellus, Chiesi, AstraZeneca and Algernon, non-financial support (equipment provision) from Vitalograph, outside the submitted work; has a patent method for generating output data licensed.

  • Support statement: I. Satia is currently supported by the E.J Moran Campbell Early Career Award, Dept of Medicine, McMaster University and was previously supported by the European Respiratory Society Respire 3 Fellowship (R3201703-00122). The study was conducted with the support of the NIHR Manchester Clinical Research Facility. J.A. Smith is funded by the NIHR Manchester Biomedical Research Centre, a Wellcome Investigator in Science Award and is an NIHR Senior Investigator.

  • Received January 26, 2021.
  • Accepted January 27, 2021.
  • Copyright ©The authors 2021. For reproduction rights and permissions contact permissions{at}ersnet.org
https://www.ersjournals.com/user-licence

References

  1. ↵
    1. Hilton E,
    2. Satia I,
    3. Holt K, et al.
    The effect of pain conditioning on experimentally evoked cough: evidence of impaired endogenous inhibitory control mechanisms in refractory chronic cough. Eur Respir J 2020; 56: 2001387. doi:10.1183/13993003.01387-2020
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Dong R,
    2. Zhang T,
    3. Wei W, et al.
    A cold environment aggravates cough hyperreactivity in guinea pigs with cough by activating the TRPA1 signaling pathway in skin. Front Physiol 2020; 11: 833. doi:10.3389/fphys.2020.00833
    OpenUrl
  3. ↵
    1. Lewis GN,
    2. Rice DA,
    3. McNair PJ
    . Conditioned pain modulation in populations with chronic pain: a systematic review and meta-analysis. J Pain 2012; 13: 936–944. doi:10.1016/j.jpain.2012.07.005
    OpenUrlCrossRefPubMed
  4. ↵
    1. Farbu EH,
    2. Skandfer M,
    3. Nielsen C, et al.
    Working in a cold environment, feeling cold at work and chronic pain: a cross-sectional analysis of the Tromsø Study. BMJ Open 2019; 9: e031248. doi:10.1136/bmjopen-2019-031248
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Skandfer M,
    2. Talykova L,
    3. Brenn T, et al.
    Low back pain among mineworkers in relation to driving, cold environment and ergonomics. Ergonomics 2014; 57: 1541–1548. doi:10.1080/00140139.2014.904005
    OpenUrlCrossRef
  6. ↵
    1. Mertens MG,
    2. Hermans L,
    3. Crombez G, et al.
    Comparison of five conditioned pain modulation paradigms and influencing personal factors in healthy adults. Eur J Pain 2021; 25: 243–256. doi:10.1002/ejp.1665
    OpenUrlPubMed
  7. ↵
    1. Lewis GN,
    2. Luke H,
    3. Rice DA, et al.
    Reliability of the conditioned pain modulation paradigm to assess endogenous inhibitory pain pathways. Pain Res Manag 2012; 17: 98–102. doi:10.1155/2012/610561
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    1. Satia I,
    2. Watson R,
    3. Scime T, et al.
    Allergen challenge increases capsaicin-evoked cough responses in patients with allergic asthma. J Allergy Clin Immunol 2019; 144: 788–795.e1. doi:10.1016/j.jaci.2018.11.050
    OpenUrl
PreviousNext
Back to top
View this article with LENS
Vol 57 Issue 3 Table of Contents
European Respiratory Journal: 57 (3)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Reply to: Noxious cold stimulation: pro–con perspectives on the hypothermic effect on experimentally evoked cough
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Reply to: Noxious cold stimulation: pro–con perspectives on the hypothermic effect on experimentally evoked cough
Imran Satia, Emma Iovoli, Kimberley Holt, Ashley A. Woodcock, John Belcher, Jaclyn A. Smith
European Respiratory Journal Mar 2021, 57 (3) 2100245; DOI: 10.1183/13993003.00245-2021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Reply to: Noxious cold stimulation: pro–con perspectives on the hypothermic effect on experimentally evoked cough
Imran Satia, Emma Iovoli, Kimberley Holt, Ashley A. Woodcock, John Belcher, Jaclyn A. Smith
European Respiratory Journal Mar 2021, 57 (3) 2100245; DOI: 10.1183/13993003.00245-2021
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Shareable PDF
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Airway immune responses to COVID-19 vaccination in COPD patients
  • Wider access to rifapentine-based regimens is needed for TB care globally
  • Screening for PVOD in heterozygous EIF2AK4 variant carriers
Show more Agora

Correspondence

  • Treatable traits in ILD: why not consider acute exacerbations?
  • Inclusion of lung health outcomes in TB treatment trials
  • Understanding confounding in Mendelian randomisation studies
Show more Correspondence

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society